Valneva SE Sponsored ADR VALN 深 沪
已收盘 03-27 16:00:00 美东时间
6.17
-0.150
-2.37%
华盛通- 最 高11.77
- 今 开6.46
- 成交量 2.76万股
- 最 低 6.17
- 昨 收 6.32
- 总市值 33.26万
- 52周最高 12.25
- 市盈率 静 --
- 换手率 51.19%
- 52周最低 5.4289
- 委 比 80.24%
- 总股本 5.39万
- 历史最高 67.84
- 量 比 0.07
- 振 幅 88.61%
- 历史最低 1.10
- 每 手 1
- 风险率 1.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Crude Oil Falls Sharply; Dell Shares Spike Higher
Dow up 2.45%, Nasdaq up 2.46%, S&P 500 up 2.19%. Consumer discretionary shares up 3.6%, energy stocks up 0.3%. Dell announces enhancements, BofA raises price target. Apogee up 17%, Tower Semi up 9%, Urban-gro up 46%. Atlantic Int'l down 13%, Linkers down 85%, Valneva down 37%. Oil down 8.1%, gold down 2.1%. European and Asian markets mixed.
03-24 03:15
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
Valneva stock drops after Phase 3 Lyme vaccine misses primary endpoint; secondary data shows efficacy as Pfizer backs regulatory submissions.
03-23 22:35
Valneva Posts €174.7M In Preliminary 2025 Revenues, Up From €169.6M In 2024, With €109.7M Cash; Guides 2026 Total Revenues Of €155M-€170M, Product Sales €145M-€160M, With Phase 3 Lyme Disease Data Expected In H1 2026
Total Revenues of €174.7 million in line with guidance, including €157.9 million in product salesStrong year-end cash position of €109.7 million, with enhanced financial flexibility following successful debt
02-19 14:44
Valneva Q3 EPS $(0.61) Misses $(0.30) Estimate, Sales $34.386M Miss $50.250M Estimate
Valneva (NASDAQ:VALN) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.30) by 103.33 percent. This is a 306.67 percent decrease over losses of $(0.15) per share from the
2025-11-21 06:26
In-Depth Examination Of 6 Analyst Recommendations For Valneva
Analysts' ratings for Valneva (NASDAQ:VALN) over the last quarter vary from bul...
2024-09-25 20:01
HC Wainwright & Co. Maintains Buy on Valneva, Lowers Price Target to $23
HC Wainwright & Co. analyst Edward White maintains Valneva (NASDAQ:VALN) with a Buy and lowers the price target from $26 to $23.
2024-09-25 18:49
Adobe, SelectQuote, Similarweb And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
2024-09-13 20:57
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
Tuesday, Valneva SE (NASDAQ:VALN) and Pfizer Inc. (NYSE:PFE) released immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their Lyme disease vaccine candidate, VLA15, given one year after receiving the first booster dose. One month after receiv...
2024-09-04 02:37
The Analyst Landscape: 6 Takes On Valneva
6 analysts have shared their evaluations of Valneva (NASDAQ:VALN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding mont...
2024-09-03 23:00
Valneva And Pfizer Announced Further Immunogenicity And Safety Data From VLA15-221 Phase 2 Study Following A Second Booster Vaccination Of Their Lyme Disease Vaccine Candidate, VLA15, Given One Year After Receiving The First Booster Dose
The immune response and safety profile of VLA15 one month after receiving the second booster dose were similar to those reported after receiving the first booster dose, showing compatibility with the anticipated benefit of a booster vaccination prior to each Lyme season.
2024-09-03 17:39
